Skip to Main Content

Paper Details

Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open-label, long-term extension study, OCTAVE open.
Aliment Pharmacol Ther
6
2022
Author NameAffiliation
Bruce E SandsIcahn School of Medicine at Mount Sinai
  • 1 - 1

Datasets

Release 1.2